Value of the extracellular water ratio for assessment of cirrhotic patients with and without ascites

Hepatology Research

Volumn 39, Issue 11, 2009, Pages 1072-1079

  Hara, Nagisa ^a   Iwasa, Motoh ^a   Iwata, Kazuko ^b   Miyachi, Hirohide ^a   Tanaka, Hideaki ^a   Takeo, Masaki ^a   Fujita, Naoki ^a   Kobayashi, Yoshinao ^a   Takei, Yoshiyuki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Ascites; Bioelectrical impedance analysis; Extracellular water; Intracellular body water; Liver cirrhosis; Total body water

Indexed keywords

ALBUMIN; FUROSEMIDE; SPIRONOLACTONE;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BODY FLUID COMPARTMENT; CONTROLLED STUDY; EXTRACELLULAR FLUID; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; IMPEDANCE; INTRACELLULAR FLUID; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTHROMBIN TIME; QUANTITATIVE ANALYSIS; RELIABILITY;

EID: 73649092420     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00546.x     Document Type: Article

References (31)

1. Panella C, Guglielmi FW, Mastronuzzi T et al. Whole-body and segmental bioelectrical parameters in chronic liver disease: effect of gender and disease stages. Hepatology 1995; 21: 352-8.
2. Prijatmoko D, Strauss BJ, Lambert JR et al. Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis. Gastroenterology 1993; 105: 1839-45.
3. McCullough AJ, Mullen KD, Kalhan SC. Measurements of total body and extracellular water in cirrhotic patients with and without ascites. Hepatology 1991; 14: 1102-11.
4. Moore KP, Wong F, Gines P et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258-66.
5. Salerno F, Borroni G, Moser P et al. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 1993; 88: 514-19.
6. Heuman DM, Abou-Assi SG Habib A et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40: 802-10.
7. Schloerb PR, Friis-Hansen BJ, Edelman IS et al. The measurement of total body water in the human subject by deuterium oxide dilution; with a consideration of the dynamics of deuterium distribution. J Clin Invest 1950; 29: 1296-310.
8. Laskey MA. Dual-energy X-ray absorptiometry and body composition. Nutrition 1996; 12: 45-51.
9. Lukaski HC. Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr 1987; 46: 537-56.
10. Holt TL, Cui C, Thomas BJ et al. Clinical applicability of bioelectric impedance to measure body composition in health and disease. Nutrition 1994; 10: 221-4.
11. Crawford DH, Halliday JW, Cooksley WG et al. Distribution of body water in patients with cirrhosis: the effect of liver transplantation. Hepatology 1993; 17: 1016-21.
12. Segal KR, Burastero S, Chun A et al. Estimation of extracellular and total body water by multiple-frequency bioelectrical-impedance measurement. Am J Cin Nutr 1991; 54: 26-9.
13. Lehnert ME, Clarke DD, Gibbons JG et al. Estimation of body water compartments in cirrhosis by multiplefrequency bioelectrical-impedance analysis. Nutrition 2001; 17: 31-4.
14. Cornish BH, Ward LC, Thomas BJ et al. Evaluation of multiple frequency bioelectrical impedance and Cole-Cole analysis for the assessment of body water volumes in healthy humans. Eur J Clin Nutr 1996; 50: 159-64.
15. Völgyi E, Tylavsky FA, Lyytikäinen A et al. Assessing body composition with DXA and bioimpedance: effects of obesity, physical activity, and age. Obesity 2008; 16: 700-5.
16. Gibson AL, Holmes JC, Desautels RL et al. Ability of new octapolar bioimpedance spectroscopy analyzers to predict 4-component-model percentage body fat in Hispanic, black, and white adults. Am J Clin Nutr 2008; 87: 332-8.
17. Tan YX, Nuñez C, Sun Y et al. New electrode system for rapid whole-body and segmental bioimpedance assessment. Med Sci Sports Exerc 1997; 29: 1269-73.
18. Pirlich M, Schütz T, Spachos T et al. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000; 32: 1208-15.
19. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-9.
20. Pugh RN, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
21. Ikeda K, Saitoh S, Kobayashi M et al. Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data. Hepatol Res 2000; 18: 252-66.
22. Moore KP, Wong F, Gines P et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258-266.
23. Figueiredo FA, De Mello Perez R, Kondo M. Effect of liver cirrhosis on body composition: evidence of significant depletion even in mild disease. J Gastroenterol Hepatol 2005; 20: 209-16.
24. Borghi A, Bedogni G, Rocchi E et al. Multi-frequency bioelectric impedance measurements for predicting body water compartments in patients with non-ascitic liver cirrhosis. Br J Nutr 1996; 76: 325-32.
25. Müller MJ, Lautz HU, Plogmann B et al. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992; 15: 782-94.
26. Planas R, Montoliu S, Ballesté B et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol 2006; 4: 1385-94.
27. Llach J, Ginès P, Arroyo V et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94: 482-7.
28. Bernardi M, Laffi G, Salvagnini M et al. Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. Liver 1993; 13: 156-62.
29. Gatta A, Angeli P, Caregaro L et al. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients. Hepatology 1991; 14: 231-6.
30. Muto Y, Sato S, Watanabe A et al. Effects of oral branchedchain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005; 3: 705-13.
31. Moriwaki H, Shiraki M, Fukushima H et al. Long-term outcome of branched-chain amino acid treatment in patients with liver cirrhosis. Hepatol Res 2008; 38: S102-6.